EU drug regulator does not refer to Eisai-Biogen Alzheimer's drug in meeting notes-February 2024-www.financetom.com

EU drug regulator does not refer to Eisai-Biogen Alzheimer's drug in meeting notes

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

EU drug regulator does not refer to Eisai-Biogen Alzheimer's drug in meeting notes

Mar 22, 2024 4:22 AM

March 22 (Reuters) - The European Union's medicines

regulator on Friday did not mention Eisai ( ESALF ) and Biogen's

Alzheimer's drug in notes and recommendations following

a meeting of a committee that reviews the use of drugs in the

region.

The European Medicines Agency had said it would review the

drug, lecanemab, this week.

Previous page： Q3 results preview on February 7: Britannia, Emami, MGL, NTPC and more Next page： Shilpa Bhatia who quit IndiGo last month returns as SpiceJet chief commercial officer

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Q3 results preview on February 7: Britannia, Emami, MGL, NTPC and more

Feb 7, 2020

Britannia, Tata steel, UPL, ACC, Mahanagar Gas, NTPC, Voltas and KEC International, among others, will report their financial results for Q3FY20 on Friday. Here is a brief preview of key Q3 results releasing today:

Shilpa Bhatia who quit IndiGo last month returns as SpiceJet chief commercial officer

Feb 7, 2020

SpiceJet said Shilpa Bhatia’s appointment comes close on the heels of a series of strategic partnership and network expansion announcements, designed to ensure a robust growth path for the airline in one of the world’s fastest growing aviation markets.

ICICI Prudential AMC’s S Naren says RBI policy gives good triggers to reduce lending rates

Feb 7, 2020

S Naren, executive director and chief investment officer, ICICI Prudential AMC spoke at length about RBI monetary policy and specific sectors in an interview with CNBC-TV18.

Emami Group to sell cement business to Nuvoco Vistas for Rs 5,500 crore

Feb 6, 2020

Emami Group on Thursday announced that it has entered into a binding agreement with Nuvoco Vistas Corporation Ltd to sell 100 per cent equity in its cement business for an enterprise value of Rs 5,500 crore, a deal that will significantly pare the conglomerate's debt.